Sol-Gel Technologies Ltd. Ordinary Shares SLGL
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $197.50 (+189.0% upside)
Key Stats
- Today's Range
- $66.95 – $71.98
- 50-Day Range
- $58.30 – $82.19
- 52-Week Range
- $27.00 – $97.97
- Volume
- 34K shs
- Average Volume
- 42K shs
- Market Cap
- $223.78 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.02%
- Days to Cover
- 1.00
About Sol-Gel Technologies Ltd. Ordinary Shares
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Related Stocks
Compare head-to-head: SLGL vs AAPL·SLGL vs NVDA·SLGL vs MSFT·SLGL vs GOOGL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.